BHVN ▼ -2.0% - Biohaven Ltd.
$BHVN - Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy
26-OCT-2026 07:30 AM ET
Share this post
More filings for $BHVN
BHVN ▲ +1.0% - Biohaven Ltd.Nov 5, 2026BHVN ▲ +2.8% - Biohaven Ltd.Oct 29, 2026BHVN ▲ +6.0% - Biohaven Ltd.Oct 29, 2026BHVN ▲ +1.5% - Biohaven Ltd.Oct 8, 2026BHVN ▼ -0.1% - Biohaven Ltd.Oct 8, 2026BHVN ▼ -0.7% - Biohaven Ltd.Sep 28, 2026
View full $BHVN filing history →💬 Comments
Loading comments…
Leave a comment